No Data
Express News | Royalty Pharma PLC : Morgan Stanley Raises Target Price to $48.00 From $46.00
Royalty Pharma to Present at Upcoming Investor Conferences
NEW YORK, May 13, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (NASDAQ:RPRX) today announced that it will participate in the following upcoming investor conferences during the month of May: RBC Capital Markets 2024
Here's What Analysts Are Forecasting For Royalty Pharma Plc (NASDAQ:RPRX) After Its First-Quarter Results
Only Four Days Left To Cash In On Royalty Pharma's (NASDAQ:RPRX) Dividend
Bank of America Securities Keeps Their Buy Rating on Royalty Pharma (RPRX)
Royalty Pharma PLC (RPRX): A Strategic SWOT Insight